Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer.
- DOI
- 10.1007/s00280-020-04055-7
- Published
- 2020 Apr
- Container
- Cancer chemotherapy and pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00280-020-04055-7,
title = {Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer.},
author = {Yamaguchi O and Imai H and Minemura H and Suzuki K and Wasamoto S and Umeda Y and Osaki T and Kasahara N and Uchino J and Sugiyama T and Ishihara S and Ishii H and Naruse I and Mori K and Kotake M and Kanazawa K and Minato K and Kagamu H and Kaira K},
year = {2020},
journal = {Cancer chemotherapy and pharmacology},
doi = {10.1007/s00280-020-04055-7},
url = {https://doi.org/10.1007/s00280-020-04055-7}
}RIS
TY - JOUR TI - Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer. AU - Yamaguchi O AU - Imai H AU - Minemura H AU - Suzuki K AU - Wasamoto S AU - Umeda Y AU - Osaki T AU - Kasahara N AU - Uchino J AU - Sugiyama T AU - Ishihara S AU - Ishii H AU - Naruse I AU - Mori K AU - Kotake M AU - Kanazawa K AU - Minato K AU - Kagamu H AU - Kaira K PY - 2020 JO - Cancer chemotherapy and pharmacology DO - 10.1007/s00280-020-04055-7 UR - https://doi.org/10.1007/s00280-020-04055-7 ER -
APA
O, Y., H, I., H, M., K, S., S, W., Y, U., T, O., N, K., J, U., T, S., S, I., H, I., I, N., K, M., M, K., K, K., K, M., H, K., & K, K. (2020). Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer.. Cancer chemotherapy and pharmacology. https://doi.org/10.1007/s00280-020-04055-7
Source records
- pubmed · retrieved 2026-09-26T07:36:15.096Z